Keyword: Byetta

Plant Construction & Process Technology

Thriving Generics

25.09.2012 - Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...

News

Bristol, AstraZeneca among Amylin Bidders

02.06.2012 - AstraZeneca and Bristol-Myers Squibb are among several pharmaceutical giants that have submitted initial bids for Amylin Pharmaceuticals, the diabetes drugmaker that is exploring a...

News

Sanofi Aims to Expand in Diabetes Market

01.06.2012 - Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...

News

Drugmaker Amylin Draws Initial Bids

28.05.2012 - Biotechnology company Amylin Pharmaceuticals has drawn initial bids from drugmakers Merck & Co and Sanofi, Bloomberg News reported on Friday, citing anonymous sources. The...